Dyslipidemias  >>  Leqvio (inclisiran)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leqvio (inclisiran) / Novartis
NCT02314442: A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Checkmark Interim data from study in healthy volunteers with elevated LDL-C at AHA 2015
Nov 2015 - Nov 2015: Interim data from study in healthy volunteers with elevated LDL-C at AHA 2015
Checkmark For hypercholesterolemia at ESC
Aug 2015 - Aug 2015: For hypercholesterolemia at ESC
Completed
1
70
Europe
ALN-PCSSC, Sterile Normal Saline (0.9% NaCl)
Alnylam Pharmaceuticals, The Medicines Company
Hypercholesterolemia
05/15
11/15

Download Options